Placental treatment with insulin-like growth factor 1 via nanoparticle differentially impacts vascular remodeling factors in guinea pig sub-placenta/decidua

Clinically, fetal growth restriction (FGR) is only detectable in later gestation, despite pathophysiological establishment likely earlier in pregnancy. Additionally, there are no effective in utero treatment options for FGR. We have developed a nanoparticle to deliver human insulin-like 1 growth fac...

Descripción completa

Detalles Bibliográficos
Autores principales: Davenport, Baylea N., Jones, Helen N., Wilson, Rebecca L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Physiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845775/
https://www.ncbi.nlm.nih.gov/pubmed/36685211
http://dx.doi.org/10.3389/fphys.2022.1055234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845775/
https://www.ncbi.nlm.nih.gov/pubmed/36685211
http://dx.doi.org/10.3389/fphys.2022.1055234

Ejemplares similares